26 related articles for article (PubMed ID: 38686772)
1. Letter to the Editor: Outcomes of patients with an intermediate risk group according to the Japanese risk classification of papillary thyroid carcinoma.
Kumari M; Chand G
World J Surg; 2024 Jan; 48(1):250. PubMed ID: 38686760
[No Abstract] [Full Text] [Related]
2. Outcomes of Patients with an Intermediate-Risk Group According to the Japanese Risk Classification of Papillary Thyroid Carcinoma.
Horiuchi K; Fujimoto M; Hidenori K; Yoshida Y; Noguchi E; Omi Y; Okamoto T
World J Surg; 2023 Oct; 47(10):2464-2473. PubMed ID: 37266697
[TBL] [Abstract][Full Text] [Related]
3. Transglottic intralaryngeal papillary thyroid carcinoma.
Varghese BT; Nair SP; Janardhan D
Oral Oncol; 2022 Aug; 131():105935. PubMed ID: 35671688
[TBL] [Abstract][Full Text] [Related]
4. Subset analysis of the Japanese risk classification guidelines for papillary thyroid carcinoma.
Ito Y; Miyauchi A; Yamamoto M; Masuoka H; Higashiyama T; Kihara M; Miya A
Endocr J; 2020 Mar; 67(3):275-282. PubMed ID: 31776303
[TBL] [Abstract][Full Text] [Related]
5. De-differentiation of papillary thyroid carcinoma into squamous cell carcinoma in an elderly patient: A case report.
Thewjitcharoen Y; Krittiyawong S; Butadej S; Nakasatien S; Polchart S; Junyangdikul P; Kanchanapituk A; Himathongkam T
Medicine (Baltimore); 2020 Apr; 99(16):e19892. PubMed ID: 32312017
[TBL] [Abstract][Full Text] [Related]
6. Authors' response: Outcomes of patients with an intermediate-risk group according to the Japanese risk classification of papillary thyroid carcinoma.
Horiuchi K
World J Surg; 2024 Jan; 48(1):251. PubMed ID: 38686772
[No Abstract] [Full Text] [Related]
7. Papillary thyroid microcarcinoma outcomes and implications for treatment.
Pearce EN; Braverman LE
J Clin Endocrinol Metab; 2004 Aug; 89(8):3710-2. PubMed ID: 15292294
[No Abstract] [Full Text] [Related]
8. Papillary thyroid carcinoma recurring as squamous cell carcinoma 10 years after total thyroidectomy: lessons from rapidly progressive papillary thyroid carcinoma.
Lee JI; Chung YJ; Lee SY
Intern Med; 2013; 52(14):1593-7. PubMed ID: 23857092
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
[TBL] [Abstract][Full Text] [Related]
10. Synchronous medullary, papillary and follicular carcinomas in the same thyroid: case report and review of literature.
Verdi D; Pennelli G; Galuppini F; Pelizzo MR; Toniato A
Updates Surg; 2013 Dec; 65(4):329-32. PubMed ID: 22527809
[No Abstract] [Full Text] [Related]
11. Papillary thyroid carcinoma with parapharyngeal and pulmonary metastases: A case report and literature review.
Ren N; Shang X; Wu G; Tian X
Asian J Surg; 2024 Apr; 47(4):1917-1918. PubMed ID: 38182519
[No Abstract] [Full Text] [Related]
12. The role of two tumor foci for predicting central lymph node metastasis in papillary thyroid carcinoma: A meta-analysis.
Feng J; Gan X; Shen F; Cai W; Xu B
Int J Surg; 2018 Apr; 52():166-170. PubMed ID: 29481991
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
